Clinical Trials Directory

Trials / Completed

CompletedNCT03668093

Evaluation of CAMBRA Versus ICCMS Caries Risk Assessment Models Acquisition On Treatment Plan

Evaluation of CAMBRA Versus ICCMS Caries Risk Assessment Models Acquisition On Treatment Plan In Young Adult Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
17 Years – 22 Years
Healthy volunteers
Accepted

Summary

randomized clinical study to evaluate 'caries management by risk assessment' Versus 'international caries classification and management system' Caries Risk Assessment Models Acquisition On Treatment Plan In Young Adult Population with null hypothesis that International Caries Classification and Management System (ICCMS™) will have the same clinical performance as Caries management by risk assessment (CAMBRA)

Detailed description

. (ICCMS™) Comprehensive Patient Care Pathway considered as significant development from the traditional system of treatment plan. Comprehensive patient care should include all recent information related to the biological, social, behavioral, cultural, systemic, and dental/oral risk factors which help development and progression of dental caries. (ICCMS™) also report all essential decisions that aid to preserve tooth structure; as diagnosis, prevention and restoration only if indicated \[9\]. Moreover ( ICCMS™) deals with caries as a disease and not as a lesion, prevent development of initial caries lesions, and restore moderate or extensive caries lesions with the aim of preserving of tooth structure as much as possible. Follow up period is selected to be 12 months, since risk category is changed for better or worse over 1-2 year.

Conditions

Interventions

TypeNameDescription
OTHERICCMcomprehensive system for caries management
OTHERCAMBRACaries risk assessment model

Timeline

Start date
2018-11-01
Primary completion
2019-11-01
Completion
2019-12-01
First posted
2018-09-12
Last updated
2020-03-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03668093. Inclusion in this directory is not an endorsement.